RESULTS	Among all patients treated with enoxaparin , there was a trend towards fewer recurrent deep-vein thromboses ( 1.3 % vs. 5.4 % ; p = 0.060 ) and pulmonary emboli ( 1.3 % vs. 4.1 % ; p = 0.17 ) compared with patients treated with unfractionated heparin .\